Cigna expects 2026–2027 margin pressure from its new rebate-free PBM model as major clients renew at lower margins, prompting a...

TD Cowen analyst Charles Rhyee maintains Cigna Group (NYSE:CI) with a Buy and lowers the price target from $387 to $333.

Goldman Sachs analyst Scott Fidel maintains Cigna Group (NYSE:CI) with a Buy and lowers the price target from $370 to $330.

JP Morgan analyst Lisa Gill maintains Cigna Group (NYSE:CI) with a Overweight and lowers the price target from $428 to $375.

Barclays analyst Andrew Mok maintains Cigna Group (NYSE:CI) with a Overweight and lowers the price target from $383 to $300.

These ten large-cap stocks led last week's declines, including Fiserv, Alexandria Real Estate, Chipotle, eBay, after weak r...

Cigna stock fell after Q3 results showed solid revenue but forecasted margin pressure in its pharmacy benefit services over the...

Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the me...